XTL BIOPHARMACEUTI (Israel) Today

Equity ratings for XTL BIOPHARMACEUTI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of July 2021 and ending today, the 21st of September 2021. Click here to learn more.
XTL BIOPHARMACEUTI cannot be verified against its exchange. It looks like XTL BIOPHARMACEUTI is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

XTL BIOPHARMACEUTI Stock Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel.. The public information regarding XTL BIOPHARMACEUTI's current market price is not available at this time.
XTL BIOPHARMACEUTI is not yet fully synchronised with the market data
XTL BIOPHARMACEUTI has some characteristics of a very speculative penny stock
XTL BIOPHARMACEUTI has high likelihood to experience some financial distress in the next 2 years
XTL BIOPHARMACEUTI has accumulated about 5.06 M in cash with (816 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Legal NameXTL BIOPHARMACEUTI
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of XTL BIOPHARMACEUTI's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
XTL BIOPHARMACEUTI (XTLB) is traded on Tel Aviv Stock Exchange in Israel and employs 2 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 34.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XTL BIOPHARMACEUTI's market, we take the total number of its shares issued and multiply it by XTL BIOPHARMACEUTI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. XTL BIOPHARMACEUTI has 514.21 M outstanding shares. XTL BIOPHARMACEUTI has accumulated about 5.06 M in cash with (816 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check XTL BIOPHARMACEUTI Probability Of Bankruptcy

XTL BIOPHARMACEUTI Stock Against Markets

Picking the right benchmark for XTL BIOPHARMACEUTI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in XTL BIOPHARMACEUTI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for XTL BIOPHARMACEUTI is critical whether you are bullish or bearish towards XTL BIOPHARMACEUTI at a given time.
XTL BIOPHARMACEUTI cannot be verified against its exchange. It looks like XTL BIOPHARMACEUTI is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with XTL BIOPHARMACEUTI stock to make a market-neutral strategy. Peer analysis of XTL BIOPHARMACEUTI could also be used in its relative valuation, which is a method of valuing XTL BIOPHARMACEUTI by comparing valuation metrics with similar companies.
Check out Your Current Watchlist. Note that the XTL BIOPHARMACEUTI information on this page should be used as a complementary analysis to other XTL BIOPHARMACEUTI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Tools for XTL BIOPHARMACEUTI Stock

When running XTL BIOPHARMACEUTI price analysis, check to measure XTL BIOPHARMACEUTI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL BIOPHARMACEUTI is operating at the current time. Most of XTL BIOPHARMACEUTI's value examination focuses on studying past and present price action to predict the probability of XTL BIOPHARMACEUTI's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move XTL BIOPHARMACEUTI's price. Additionally, you may evaluate how the addition of XTL BIOPHARMACEUTI to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go